Back to Results
First PageMeta Content
Endocrine diseases / Chronic / Osteoporosis / Indometacin / Medicine / Chemistry / Health


Health Quality & Safety Commission Medication Safety 2014 and beyond Leanne Te Karu and Marama Parore
Add to Reading List

Document Date: 2014-11-30 22:40:06


Open Document

File Size: 1,21 MB

Share Result on Facebook

Company

NEC / /

IndustryTerm

pharmaceutical schedule deficits / /

MedicalCondition

relative disease / cancers / Cirrhosis/ other chronic liver disease / gout / ADHD / movement disorders / Diabetes mellitus / Childhood conduct disorders / Spina bifida / Parkinson’s disease / Schizophrenia / bacterial infections / BPH [BPH] NSAIDS/gout / disease / Hepatitis B/C / osteoporosis / infectious diseases / HIV/AIDS / Epilepsy / Hepatitis / Substance use disorders / bowel disease / incl septicaemia / Cystic Fibrosis / Anxiety disorders / Rheumatoid arthritis / MS / Peptic ulcer disease / affective disorders / Chronic / depression / cirrhosis / Inflammatory / Tuberculosis / asthma / /

Organization

New Zealand Pharmacovigilance Centre / /

Person

Leanne Te Karu / /

Product

clozapine / disulfiram / Safety Commission Medication / /

Technology

Alpha / /

SocialTag